• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌胸腔镜肺叶和肺段切除术后患者报告结局量表(PROMs)的比较

Comparison of patient-reported outcome measures (PROMs) after thoracoscopic lobar and sublobar resections for non-small cell lung cancer.

作者信息

Hassan Mohamed, Hojski Aljaz, Oliveira Leonel, Gahl Brigitta, Rüter Florian, Lardinois Didier

机构信息

Department of Thoracic Surgery, University Hospital Basel, Basel, Switzerland.

Quality Management and Value Based Healthcare, University Hospital Basel, Basel, Switzerland.

出版信息

J Thorac Dis. 2025 Jun 30;17(6):3727-3736. doi: 10.21037/jtd-2025-173. Epub 2025 Jun 19.

DOI:10.21037/jtd-2025-173
PMID:40688323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12268580/
Abstract

BACKGROUND

Surgical resection of early-stage non-small cell lung cancer (NSCLC) is associated with prolonged survival. However, there is a paucity of research investigating the long-term effects of the extent of lung resection on patients' quality of life. The aim of the study was to investigate the patient-reported outcome measures (PROMs) after thoracoscopic anatomic lung resection (lobar and sublobar) for NSCLC.

METHODS

We conducted a retrospective analysis of prospectively collected PROMs following thoracoscopic anatomic lung resection (lobar and sublobar) for NSCLC stages I-IIA. The primary endpoint was the change in physical function scores at 3, 6, 12, and 24 months post-surgery. Secondary endpoints included changes in patient-reported shortness of breath and coughing scores post-surgery between the two resection types.

RESULTS

A total of 57 patients were included in this study, with 26 patients undergoing lobar resection and 31 undergoing sublobar resection. The mean age was 71.4±8.3 years in the lobar resection group and 70.7±10.5 years in the sublobar resection group (P=0.77). There were no significant differences in the preoperative lung function tests between the two groups [mean forced expiratory volume in the first second (FEV1) was 88%±17.1% in the lobar group and 83.4%±19.3% in the sublobar group, P=0.37]. The mean baseline physical functioning scores were 78±23 in the lobar group and 73±30 in the sublobar group (P=0.44). Changes in physical functioning scores did not differ significantly between lobar and sublobar resection groups (P=0.76) during the study period and up to 2 years after the surgery. Additionally, the type of lung resection had no effect on symptom scores for shortness of breath (P=0.24) or coughing (P=0.73).

CONCLUSIONS

Patient-reported physical function, shortness of breath, and coughing did not significantly change from 3 months to 2 years following thoracoscopic anatomical lung resection in patients with NSCLC. The type of lung resection (lobar or sublobar) also had no significant effect on these outcomes.

摘要

背景

早期非小细胞肺癌(NSCLC)手术切除可延长生存期。然而,关于肺切除范围对患者生活质量的长期影响的研究较少。本研究的目的是调查非小细胞肺癌患者接受胸腔镜解剖性肺切除(肺叶和肺段)后的患者报告结局指标(PROMs)。

方法

我们对前瞻性收集的I-IIA期非小细胞肺癌患者接受胸腔镜解剖性肺切除(肺叶和肺段)后的PROMs进行了回顾性分析。主要终点是术后3、6、12和24个月时身体功能评分的变化。次要终点包括两种切除类型术后患者报告的呼吸急促和咳嗽评分的变化。

结果

本研究共纳入57例患者,其中26例行肺叶切除,31例行肺段切除。肺叶切除组的平均年龄为71.4±8.3岁,肺段切除组为70.7±10.5岁(P=0.77)。两组术前肺功能测试无显著差异[肺叶组第一秒用力呼气量(FEV1)平均为88%±17.1%,肺段组为83.4%±19.3%,P=0.37]。肺叶组的平均基线身体功能评分为78±23,肺段组为73±30(P=0.44)。在研究期间及术后2年内,肺叶和肺段切除组的身体功能评分变化无显著差异(P=0.76)。此外,肺切除类型对呼吸急促(P=0.24)或咳嗽(P=0.73)的症状评分没有影响。

结论

非小细胞肺癌患者接受胸腔镜解剖性肺切除后3个月至2年,患者报告的身体功能、呼吸急促和咳嗽情况没有显著变化。肺切除类型(肺叶或肺段)对这些结局也没有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/f3073c9541b8/jtd-17-06-3727-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/7cb2a974a2e7/jtd-17-06-3727-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/4f4f541cc155/jtd-17-06-3727-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/4df055635a8c/jtd-17-06-3727-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/9e8b31a6bfec/jtd-17-06-3727-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/a7a28eeba44f/jtd-17-06-3727-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/f3073c9541b8/jtd-17-06-3727-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/7cb2a974a2e7/jtd-17-06-3727-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/4f4f541cc155/jtd-17-06-3727-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/4df055635a8c/jtd-17-06-3727-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/9e8b31a6bfec/jtd-17-06-3727-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/a7a28eeba44f/jtd-17-06-3727-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/652a/12268580/f3073c9541b8/jtd-17-06-3727-f6.jpg

相似文献

1
Comparison of patient-reported outcome measures (PROMs) after thoracoscopic lobar and sublobar resections for non-small cell lung cancer.非小细胞肺癌胸腔镜肺叶和肺段切除术后患者报告结局量表(PROMs)的比较
J Thorac Dis. 2025 Jun 30;17(6):3727-3736. doi: 10.21037/jtd-2025-173. Epub 2025 Jun 19.
2
The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: results from CALGB 140503 (Alliance).肺叶或肺段切除术后淋巴结清扫范围与无病生存期无关:CALGB 140503(联盟)研究结果
J Thorac Cardiovasc Surg. 2025 Jun 16. doi: 10.1016/j.jtcvs.2025.06.007.
3
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.用于男性膀胱出口梗阻诊断和管理的尿动力学检查:UPSTREAM非劣效性随机对照试验的长期随访
Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675.
4
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.肺段或亚肺叶切除术治疗外周型ⅠA 期非小细胞肺癌。
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
5
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
6
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水用于囊性纤维化
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4.
7
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
8
Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.常规胸部物理治疗与其他气道清除技术在囊性纤维化中的比较。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD002011. doi: 10.1002/14651858.CD002011.pub3.
9
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non‑small cell lung cancer.对于患有Ia期非小细胞肺癌的八旬及以上老人,肺段切除术并不逊色于肺叶切除术。
Transl Cancer Res. 2025 May 30;14(5):2966-2980. doi: 10.21037/tcr-2024-2575. Epub 2025 May 14.
10
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.

本文引用的文献

1
Changes in quality of life of early-stage lung cancer patients undergoing sublobar resection: a systematic review.接受亚肺叶切除的早期肺癌患者生活质量的变化:一项系统评价
Front Surg. 2025 Feb 28;12:1542036. doi: 10.3389/fsurg.2025.1542036. eCollection 2025.
2
Patient-Reported Outcome Measures in Cancer Care: An Updated Systematic Review and Meta-Analysis.癌症护理中的患者报告结局测量:更新的系统评价和荟萃分析。
JAMA Netw Open. 2024 Aug 1;7(8):e2424793. doi: 10.1001/jamanetworkopen.2024.24793.
3
Self-reported dyspnoea and shortness of breathing deterioration in long-term survivors after segmentectomy or lobectomy for early-stage lung cancer.
早期肺癌患者行肺段切除或肺叶切除术后长期生存者的自我报告呼吸困难和呼吸急促恶化。
Eur J Cardiothorac Surg. 2024 May 3;65(5). doi: 10.1093/ejcts/ezae200.
4
Cohort study investigating evolution and factors associated with dyspnoea after anatomic lung resection.一项队列研究,旨在调查解剖性肺切除术后呼吸困难的演变情况及相关因素。
J Thorac Dis. 2024 Jan 30;16(1):113-122. doi: 10.21037/jtd-23-835. Epub 2024 Jan 15.
5
Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer.胸腔镜辅助或开放性肺叶切除术治疗早期肺癌。
NEJM Evid. 2022 Mar;1(3):EVIDoa2100016. doi: 10.1056/EVIDoa2100016. Epub 2022 Jan 18.
6
Quality of life after lung cancer surgery: sublobar resection versus lobectomy.肺癌手术后的生活质量:亚肺叶切除术与肺叶切除术比较。
BMC Surg. 2023 Nov 18;23(1):353. doi: 10.1186/s12893-023-02259-1.
7
European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer.欧洲胸外科医师协会关于原发性肺癌肺段切除术技术标准的专家共识建议
Eur J Cardiothorac Surg. 2023 Jun 1;63(6). doi: 10.1093/ejcts/ezad224.
8
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.肺段或亚肺叶切除术治疗外周型ⅠA 期非小细胞肺癌。
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
9
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
10
Comparison of postoperative cough-related quality of life and recovery between sublobectomy and lobectomy for early-stage non-small cell lung cancer patients: a longitudinal study.肺段切除与肺叶切除治疗早期非小细胞肺癌患者术后咳嗽相关生活质量和恢复的比较:一项纵向研究。
BMC Pulm Med. 2022 Apr 23;22(1):154. doi: 10.1186/s12890-022-01954-8.